Literature DB >> 35362879

circ3323 Motivates Host Gene to Promote the Aggressiveness of Bladder Cancer.

Xingyu Wu1, Wei Cao1, Chao Lu1, Li Zuo1, Xiaowu Liu2, Minjun Qi3.   

Abstract

Bladder cancer (BCa) is the most common cancer in the urinary system with high recurrence rate and poor prognosis. Circular RNA (circRNA) is a novel subclass of noncoding-RNA which participate in progression of BCa. Here, we identified a novel circRNA-circ3323 and aimed to investigate the role of circ3323 in progression of BCa. Public data of RNA sequencing was used to identify significant circRNA related to BCa. The role of circRNAs in progression of BCa was assessed in cytotoxicity assay, transwell assay and flow cytometry. Biotin-coupled RNA pull-down and fluorescence in situ hybridization were performed to evaluate the interaction between circRNAs and miRNAs. The expression of circ3323 was higher in BCa tissues and cells than in normal samples. Experiments in vitro showed that the knockdown of circ3323 inhibited cell proliferation and impeded the metastasis of BCa cells. Mechanistically, we demonstrated that circ3323 acts as a sponge for miR-186-5p and promotes host gene APP's expression. Clinically, circ3323 predicts worse overall survival of BCa patients, indicating its prognostic value. Our study identified that circ3323 modulates metastasis of BCa through miR-186-5p/APP axis and may serve as a promising prognostic biomarker for BCa, which provides novel insights into treatment of BCa.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bladder cancer; Malignant progression; circ3323; miRNA-186

Year:  2022        PMID: 35362879     DOI: 10.1007/s10528-022-10210-x

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  16 in total

1.  MiR-185-5p suppresses acute myeloid leukemia by inhibiting GPX1.

Authors:  Bo Pang; Hanwen Mao; Jing Wang; Wenjing Yang
Journal:  Microvasc Res       Date:  2021-12-03       Impact factor: 3.514

2.  MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.

Authors:  Hong-Xia Fan; Yu-Jie Feng; Xiao-Pei Zhao; Yu-Ze He; Hua Tang
Journal:  Life Sci       Date:  2018-10-09       Impact factor: 5.037

3.  Amyloid Precursor Protein Is Associated with Aggressive Behavior in Nonluminal Breast Cancers.

Authors:  Julia Y S Tsang; Michelle A Lee; Yun-Bi Ni; Siu-Ki Chan; Sai-Yin Cheung; Wai-Wa Chan; Kwok-Fai Lau; Gary M K Tse
Journal:  Oncologist       Date:  2018-08-14

4.  Predictive Efficacy of MiR-125b-5p, MiR-17-5p, and MiR-185-5p in Liver Metastasis and Chemotherapy Response Among Advanced Stage Colorectal Cancer Patients.

Authors:  Daniel Sur; Loredana Balacescu; Simona S Cainap; Simona Visan; Laura Pop; Claudia Burz; Andrei Havasi; Rares Buiga; Calin Cainap; Alexandru Irimie; Ovidiu Balacescu
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

5.  miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma.

Authors:  Yuexiang Niu; Gongen Tang
Journal:  Oncol Lett       Date:  2019-03-13       Impact factor: 2.967

6.  Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.

Authors:  Julia Y S Tsang; Michelle A Lee; Tsz-Hei Chan; Joshua Li; Yun-Bi Ni; Yan Shao; Siu-Ki Chan; Sai-Yin Cheungc; Kwok-Fai Lau; Gary M K Tse
Journal:  EBioMedicine       Date:  2018-11-20       Impact factor: 8.143

7.  miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2.

Authors:  Elif Değerli; Vildan Torun; Demet Cansaran-Duman
Journal:  Biol Res       Date:  2020-05-04       Impact factor: 5.612

8.  circPHIP promotes oral squamous cell carcinoma progression by sponging miR-142-5p and regulating PHIP and ACTN4 expression.

Authors:  Wen Su; Yuehong Shen; Yufan Wang; Feng Wang; Xia Hong; Yuling Chen; Yuntao Lin; Hongyu Yang
Journal:  Mol Ther Nucleic Acids       Date:  2020-11-04       Impact factor: 8.886

9.  circRNA circARNT2 Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting the miR-155-5p/PDK1 Axis.

Authors:  Yueyong Li; Yingjun Zhang; Shuai Zhang; Deyou Huang; Baosheng Li; Gencheng Liang; Yingning Wu; Qiulan Jiang; Longhua Li; Cheng Lin; Zhonghen Wei; Lingzhang Meng
Journal:  Mol Ther Nucleic Acids       Date:  2020-09-03       Impact factor: 8.886

10.  β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells.

Authors:  Dan Liu; Li Zha; Yuchen Liu; Xuan Zhao; Xiyue Xu; Shuci Liu; Wen Ma; Junnian Zheng; Ming Shi
Journal:  Cancer Sci       Date:  2020-10-27       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.